Case ID	Project	Primary Site	Gender	Files	Seq	Exp	SNV	CNV	Meth	Clinical	Bio	# Mutations	# Genes	Slides
TCGA-A5-A0G2	TCGA-UCEC	Corpus uteri	Female	69	8	4	16	9	3	11	17	2	1	3
TARGET-10-PARSHV	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	20	2	0	14	0	0	3	1	1	1	0
MP2PRT-PAVAXA	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Female	36	7	2	16	2	0	3	0	1	1	0
2218	BEATAML1.0-COHORT	Hematopoietic and reticuloendothelial systems	Male	40	6	2	28	0	0	0	0	1	1	0
TCGA-3N-A9WD	TCGA-SKCM	Skin	Male	67	6	4	16	11	3	8	14	1	1	2
MMRF_1687	MMRF-COMMPASS	Hematopoietic and reticuloendothelial systems	Male	18	4	0	14	0	0	0	0	1	1	0
HCM-BROD-0834-C43	HCMI-CMDC	Skin	Male	71	12	4	32	4	6	1	0	1	1	0
TARGET-10-PAPFKA	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	20	2	0	14	0	0	3	1	1	1	0
TCGA-GN-A268	TCGA-SKCM	Skin	Female	67	6	4	16	11	3	8	14	1	1	2
MMRF_1861	MMRF-COMMPASS	Hematopoietic and reticuloendothelial systems	Female	27	7	2	14	0	0	0	0	1	1	0
MP2PRT-PAPMVR	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
MP2PRT-PAVTJD	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	33	7	2	13	2	0	3	0	2	1	0
TCGA-GN-A4U3	TCGA-SKCM	Skin	Male	66	6	4	16	11	3	8	14	1	1	2
MP2PRT-PAUEFP	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
2208	BEATAML1.0-COHORT	Hematopoietic and reticuloendothelial systems	Male	16	2	0	14	0	0	0	0	1	1	0
TCGA-AG-3894	TCGA-READ	Rectum	Male	68	8	4	16	11	3	9	17	1	1	3
HTMCP-03-06-02343	CGCI-HTMCP-CC	Cervix uteri	Female	27	2	0	14	0	0	4	7	1	1	2
MP2PRT-PATEWZ	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Female	36	7	2	16	2	0	3	0	1	1	0
MP2PRT-PAUWMA	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
TCGA-EE-A185	TCGA-SKCM	Skin	Female	69	8	4	16	11	3	8	14	1	1	2
MP2PRT-PAVJUN	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Female	36	7	2	16	2	0	3	0	1	1	0
TARGET-10-PARJLF	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	20	2	0	14	0	0	3	1	1	1	0
TARGET-10-PANZYY	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	20	2	0	14	0	0	3	1	1	1	0
MP2PRT-PARKKC	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
TARGET-10-PARGLW	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Male	20	2	0	14	0	0	3	1	1	1	0
TCGA-G2-A2EF	TCGA-BLCA	Bladder	Male	77	12	4	16	11	3	10	17	1	1	5
2197	BEATAML1.0-COHORT	Hematopoietic and reticuloendothelial systems	Female	25	5	2	14	0	0	0	0	1	1	0
MP2PRT-PAUFSB	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
MP2PRT-PAVNRM	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0
TARGET-10-PANZBY	TARGET-ALL-P2	Hematopoietic and reticuloendothelial systems	Female	20	2	0	14	0	0	3	1	1	1	0
TCGA-ER-A2NB	TCGA-SKCM	Skin	Male	67	6	4	16	11	3	8	14	1	1	2
TCGA-D1-A16X	TCGA-UCEC	Corpus uteri	Female	70	8	4	16	11	3	11	16	1	1	2
MMRF_1771	MMRF-COMMPASS	Hematopoietic and reticuloendothelial systems	Male	27	7	2	14	0	0	0	0	1	1	0
TCGA-F5-6863	TCGA-READ	Rectum	Female	73	8	4	16	11	3	9	17	1	1	3
TCGA-FS-A1ZE	TCGA-SKCM	Skin	Male	68	8	4	16	11	3	8	14	1	1	2
MMRF_1423	MMRF-COMMPASS	Hematopoietic and reticuloendothelial systems	Female	27	7	2	14	0	0	0	0	1	1	0
MP2PRT-PASVFY	MP2PRT-ALL	Hematopoietic and reticuloendothelial systems	Male	36	7	2	16	2	0	3	0	1	1	0